Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2024. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5389614018 | Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5389615017 | Cytarabine liposome and daunorubicin liposome only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) | Is a | Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) | Is a | Product containing only cytarabine liposome and daunorubicin liposome (medicinal product) | true | Inferred relationship | Some | ||
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) | Has active ingredient | Cytarabine liposome | true | Inferred relationship | Some | 1 | |
Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) | Has active ingredient | Daunorubicin liposome (substance) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Is a | True | Product containing only cytarabine liposome and daunorubicin liposome in parenteral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets